Paysign, Inc. (NASDAQ:PAYS) Shares Sold by Royce & Associates LP

Royce & Associates LP decreased its holdings in shares of Paysign, Inc. (NASDAQ:PAYSFree Report) by 93.6% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 14,153 shares of the company’s stock after selling 207,558 shares during the period. Royce & Associates LP’s holdings in Paysign were worth $43,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. SG Americas Securities LLC boosted its stake in shares of Paysign by 33.5% during the fourth quarter. SG Americas Securities LLC now owns 15,508 shares of the company’s stock worth $47,000 after buying an additional 3,895 shares during the period. Bard Associates Inc. boosted its stake in shares of Paysign by 19.7% during the fourth quarter. Bard Associates Inc. now owns 33,450 shares of the company’s stock worth $101,000 after buying an additional 5,497 shares during the period. Rhumbline Advisers boosted its stake in shares of Paysign by 13.7% during the fourth quarter. Rhumbline Advisers now owns 44,284 shares of the company’s stock worth $134,000 after buying an additional 5,339 shares during the period. BNP Paribas Financial Markets boosted its stake in shares of Paysign by 257.0% during the third quarter. BNP Paribas Financial Markets now owns 44,793 shares of the company’s stock worth $164,000 after buying an additional 32,245 shares during the period. Finally, Barclays PLC boosted its stake in shares of Paysign by 327.4% during the third quarter. Barclays PLC now owns 47,090 shares of the company’s stock worth $173,000 after buying an additional 36,071 shares during the period. Institutional investors and hedge funds own 25.89% of the company’s stock.

Insider Buying and Selling

In other Paysign news, insider Topline Capital Management, Ll sold 231,187 shares of the stock in a transaction dated Friday, December 27th. The shares were sold at an average price of $3.31, for a total value of $765,228.97. Following the completion of the transaction, the insider now directly owns 5,859,046 shares of the company’s stock, valued at approximately $19,393,442.26. This trade represents a 3.80 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Mark Newcomer sold 100,000 shares of the stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $2.73, for a total transaction of $273,000.00. Following the completion of the transaction, the chief executive officer now directly owns 8,936,886 shares of the company’s stock, valued at approximately $24,397,698.78. This trade represents a 1.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 927,087 shares of company stock valued at $2,872,039 over the last ninety days. Corporate insiders own 23.40% of the company’s stock.

Paysign Stock Down 0.8 %

NASDAQ PAYS opened at $2.34 on Friday. The stock has a market capitalization of $125.30 million, a P/E ratio of 15.60 and a beta of 0.93. Paysign, Inc. has a 52-week low of $2.25 and a 52-week high of $5.59. The firm has a 50-day moving average price of $2.69 and a 200 day moving average price of $3.29.

Analyst Ratings Changes

Separately, Lake Street Capital started coverage on shares of Paysign in a research note on Friday, December 20th. They set a “buy” rating and a $6.00 target price for the company.

Get Our Latest Analysis on Paysign

Paysign Company Profile

(Free Report)

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.

Read More

Want to see what other hedge funds are holding PAYS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Paysign, Inc. (NASDAQ:PAYSFree Report).

Institutional Ownership by Quarter for Paysign (NASDAQ:PAYS)

Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.